ADVENTRX To Present At The 15th Annual BIO CEO & Investor
Conference On February 12
SAN DIEGO, Feb. 5, 2013 /PRNewswire/ -- ADVENTRX
Pharmaceuticals, Inc. (NYSE MKT: ANX) today announced that the
Company's Chief Executive Officer, Brian M.
Culley, will present at the 15th Annual
BIO CEO & Investor Conference on
Tuesday, February 12, 2013 at
10:00a.m. Eastern time in the
Duke of Windsor Salon at The
Waldorf=Astoria Hotel in New
York.
Interested parties can access a live audio webcast and slide
presentation on the ADVENTRX Pharmaceuticals web site at
www.adventrx.com. An archived presentation will be available on the
web site for 30 days.
About ADVENTRX Pharmaceuticals
ADVENTRX
Pharmaceuticals is a biopharmaceutical company developing
proprietary product candidates to treat various diseases and
conditions. The Company's lead product candidate, ANX-188, has
potential to reduce ischemic tissue injury and end-organ damage by
restoring microvascular function, which is compromised in a wide
range of serious and life-threatening diseases and
conditions. The Company is recruiting subjects in EPIC, a
randomized, double-blind, placebo-controlled phase 3 study of
ANX-188 in patients with sickle cell disease. More information can
be found on the Company's web site at www.adventrx.com.
(Logo: http://photos.prnewswire.com/prnh/20120612/LA22456LOGO-a)
SOURCE ADVENTRX Pharmaceuticals, Inc.
